Venlafaxine - Pfizer

Drug Profile

Venlafaxine - Pfizer

Alternative Names: Dobupal; Efexor XR; Effexor; Effexor XR; Elafax; WY 45030; WY 45651; WY 45655

Latest Information Update: 05 Apr 2018

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Wyeth
  • Developer Pfizer
  • Class Antidepressants; Anxiolytics; Cyclohexanols; Dimethylamines; Small molecules
  • Mechanism of Action Adrenergic uptake inhibitors; Serotonin uptake inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Marketed Generalised anxiety disorder; Major depressive disorder; Panic disorder; Social phobia

Most Recent Events

  • 01 Mar 2018 Pfizer and Sumitomo Dainippon Pharma agree to co-promote Venlafaxine for Major depressive disorder in Japan (PO,capsules)
  • 01 Jul 2016 Pfizer completes a phase I trial in Healthy volunteers in USA (NCT02637193)
  • 15 Mar 2016 Biomarkers information updated
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top